CN102725304B - 用于亲和色谱法的冲洗溶液和方法 - Google Patents

用于亲和色谱法的冲洗溶液和方法 Download PDF

Info

Publication number
CN102725304B
CN102725304B CN201080057457.6A CN201080057457A CN102725304B CN 102725304 B CN102725304 B CN 102725304B CN 201080057457 A CN201080057457 A CN 201080057457A CN 102725304 B CN102725304 B CN 102725304B
Authority
CN
China
Prior art keywords
protein
arginine
column
matrix
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080057457.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN102725304A (zh
Inventor
A·弗劳恩舒
K·比尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102725304(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN102725304A publication Critical patent/CN102725304A/zh
Application granted granted Critical
Publication of CN102725304B publication Critical patent/CN102725304B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201080057457.6A 2009-12-18 2010-12-17 用于亲和色谱法的冲洗溶液和方法 Active CN102725304B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28805909P 2009-12-18 2009-12-18
US61/288,059 2009-12-18
PCT/EP2010/070076 WO2011073389A1 (en) 2009-12-18 2010-12-17 Wash solution and method for affinity chromatography

Publications (2)

Publication Number Publication Date
CN102725304A CN102725304A (zh) 2012-10-10
CN102725304B true CN102725304B (zh) 2015-12-09

Family

ID=43598315

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080057457.6A Active CN102725304B (zh) 2009-12-18 2010-12-17 用于亲和色谱法的冲洗溶液和方法

Country Status (18)

Country Link
US (3) US9505803B2 (enExample)
EP (2) EP2513134B1 (enExample)
JP (2) JP5909450B2 (enExample)
KR (1) KR101858266B1 (enExample)
CN (1) CN102725304B (enExample)
AU (1) AU2010332778B2 (enExample)
BR (1) BR112012014937B1 (enExample)
CA (1) CA2784278C (enExample)
DK (2) DK2513134T3 (enExample)
ES (2) ES2651065T3 (enExample)
IL (1) IL220164B (enExample)
LT (2) LT2513134T (enExample)
MX (1) MX2012007103A (enExample)
PL (2) PL3272764T3 (enExample)
PT (2) PT3272764T (enExample)
RU (1) RU2564569C2 (enExample)
SG (2) SG10201408384PA (enExample)
WO (1) WO2011073389A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
KR20110091678A (ko) * 2008-10-20 2011-08-12 아보트 러보러터리즈 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제
JP5909450B2 (ja) * 2009-12-18 2016-04-26 ノバルティス アーゲー 洗浄溶液及びアフィニティークロマトグラフィーの方法
ES2492681T3 (es) * 2010-01-22 2014-09-10 Boehringer Ingelheim International Gmbh Método cromatográfico para purificar proteínas que contienen FC
CA2834300C (en) * 2011-06-01 2022-01-11 Novartis Ag Wash solution and method for affinity chromatography
ES2971444T3 (es) 2011-10-11 2024-06-05 F Hoffmann Lar Roche Ag Ensamblaje mejorado de anticuerpos biespecíficos
EP2997036B1 (en) 2013-05-15 2021-03-03 Medimmune Limited Purification of recombinantly produced polypeptides
EP3041593B1 (en) * 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Method of cleaning a chromatography material for its reuse
EP2986307A4 (en) 2014-01-03 2017-04-12 Bio-rad Laboratories, Inc. Removal of impurities from protein a eluates
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
KR102490956B1 (ko) 2015-03-13 2023-01-19 브리스톨-마이어스 스큅 컴퍼니 불순물을 제거하기 위한 크로마토그래피 동안의 알칼리성 세척의 용도
PL3337812T3 (pl) 2015-08-21 2021-10-11 F. Hoffmann-La Roche Ag Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa
CN107849122B (zh) * 2015-08-21 2022-01-25 豪夫迈·罗氏有限公司 用低电导率洗涤缓冲液进行亲和层析纯化
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US11708390B2 (en) 2016-05-11 2023-07-25 Cytiva Bioprocess R&D Ab Method of storing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
MX392628B (es) * 2016-07-25 2025-03-24 Cephalon Inc Amortiguador de lavado de cromatografia de afinidad.
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CA3067735A1 (en) 2017-08-17 2019-02-21 Just Biotherapeutics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants
CN107793469B (zh) * 2017-10-16 2021-07-30 上海药明生物技术有限公司 一种去除宿主细胞蛋白含量的亲和纯化工艺
AU2018392697B2 (en) * 2017-12-21 2025-08-14 Genzyme Corporation Methods for enhanced removal of impurities during protein a chromatography
CN119881293A (zh) 2018-03-21 2025-04-25 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
BR112020019882A2 (pt) 2018-04-02 2021-01-05 Amgen Inc. Composições de erenumabe e seus usos
EP3791172B1 (en) * 2018-05-08 2023-06-28 Waters Technologies Corporation Methods, compositions and kits useful for ph gradient cation exchange chromatography
EP3837273B1 (en) * 2018-08-14 2025-09-24 Bristol-Myers Squibb Company Improved protein recovery
US20230399358A1 (en) * 2019-10-08 2023-12-14 North Carolina State University Immunoglobulin purification peptides and their use
CA3176109A1 (en) * 2020-03-27 2021-09-30 Haemalogix Pty Ltd Composition and method
JP2023523324A (ja) * 2020-04-27 2023-06-02 アレクシオン ファーマシューティカルズ， インコーポレイテッド 抗体のプロテインａクロマトグラフィー精製
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
CR20250204A (es) * 2022-12-12 2025-06-06 H Lundbeck As Lavado con arginina en la purificación de proteínas
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680426A (zh) * 2004-01-21 2005-10-12 味之素株式会社 防止抗体变性的精制方法
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
CN101511859A (zh) * 2006-06-02 2009-08-19 惠氏公司 TGF-β超家族的蛋白质和肽用于纯化和治疗方法的用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
JP4031049B2 (ja) 1996-11-27 2008-01-09 ジェネンテック，インコーポレーテッド タンパク質精製
ATE321066T1 (de) 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
DE69919701T2 (de) 1998-06-01 2005-09-15 Genentech, Inc., South San Francisco Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie
WO2002072615A1 (en) 2001-03-09 2002-09-19 Chugai Seiyaku Kabushiki Kaisha Method of purifying protein
DK1714982T3 (da) 2001-06-05 2009-05-04 Genetics Inst Llc Fremgangsmåde til rensning af stærkt anioniske proteiner
JP4460302B2 (ja) 2002-02-05 2010-05-12 ジェネンテック インコーポレイテッド タンパク質精製法
SI1561756T1 (sl) 2002-09-11 2016-02-29 Chugai Seiyaku Kabushiki Kaisha Postopek čiščenja proteinov
MXPA05004290A (es) * 2002-10-24 2005-11-23 Enos Pharmaceuticals Inc Formulaciones de l-arginina de liberacion sostenida, y metodos para su fabricacion y uso.
MXPA05005558A (es) * 2002-11-26 2005-07-26 Protein Design Labs Inc Anticuerpos quimericos y humanizados para integrina ( 5 ( 1 que modulan la angiogenesis.
WO2004062689A1 (en) * 2003-01-08 2004-07-29 Chiron Corporation Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1601697B1 (en) 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
AU2004286938B2 (en) 2003-10-27 2011-06-30 Wyeth Removal of high molecular weight aggregates using hydroxyapatite chromatography
DE602006003108D1 (de) 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
KR101482791B1 (ko) * 2005-03-11 2015-01-21 와이어쓰 엘엘씨 약한 분배성 크로마토그래피법
CN101365948B (zh) 2006-01-06 2012-11-07 Emd密理博公司 亲和层析基质及其制备和使用方法
US8263750B2 (en) 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
WO2007108955A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
US7754689B2 (en) 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
ES2755386T5 (es) 2006-08-28 2023-04-05 Ares Trading Sa Proceso para la purificación de proteínas que contienen fragmentos Fc
JP2010516651A (ja) 2007-01-17 2010-05-20 メルク セローノ ソシエテ アノニム Ｆｃ含有タンパク質の精製のための方法
MX2009012786A (es) 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
US20110105725A1 (en) 2008-05-15 2011-05-05 Novo Nordisk A/S Antibody purification process
JP5529869B2 (ja) 2008-08-14 2014-06-25 メルク・シャープ・アンド・ドーム・コーポレーション プロテインａアフィニティークロマトグラフィーを用いる抗体の精製方法
JP5909450B2 (ja) 2009-12-18 2016-04-26 ノバルティス アーゲー 洗浄溶液及びアフィニティークロマトグラフィーの方法
CA2834300C (en) 2011-06-01 2022-01-11 Novartis Ag Wash solution and method for affinity chromatography

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680426A (zh) * 2004-01-21 2005-10-12 味之素株式会社 防止抗体变性的精制方法
CN101511859A (zh) * 2006-06-02 2009-08-19 惠氏公司 TGF-β超家族的蛋白质和肽用于纯化和治疗方法的用途
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EVective elution of antibodies by arginine and arginine derivatives in aYnity column chromatography;Daisuke Ejima et al;《ANALYTICAL BIOCHEMISTRY》;20050626;第345卷(第2期);第250-257页 *
单克隆抗体纯化研究进展;应国清等;《中国医药工业杂志》;20091231;第39卷(第10期);第777-783页 *

Also Published As

Publication number Publication date
PT3272764T (pt) 2024-04-24
ES2982297T3 (es) 2024-10-15
MX2012007103A (es) 2012-07-17
SG181771A1 (en) 2012-07-30
CA2784278A1 (en) 2011-06-23
IL220164B (en) 2019-02-28
US20170044211A1 (en) 2017-02-16
DK2513134T3 (en) 2017-12-18
PL3272764T3 (pl) 2024-06-10
KR20120109506A (ko) 2012-10-08
BR112012014937A2 (pt) 2016-03-08
CA2784278C (en) 2019-02-26
LT3272764T (lt) 2024-05-10
AU2010332778A1 (en) 2012-07-19
AU2010332778B2 (en) 2015-03-19
KR101858266B1 (ko) 2018-05-15
CN102725304A (zh) 2012-10-10
JP2016128495A (ja) 2016-07-14
PL2513134T3 (pl) 2018-02-28
EP3272764B1 (en) 2024-02-07
RU2564569C2 (ru) 2015-10-10
US9505803B2 (en) 2016-11-29
EP3272764A1 (en) 2018-01-24
RU2012130151A (ru) 2014-01-27
PT2513134T (pt) 2017-12-14
US20120283416A1 (en) 2012-11-08
IL220164A0 (en) 2012-07-31
JP5909450B2 (ja) 2016-04-26
LT2513134T (lt) 2017-11-27
US20190233469A1 (en) 2019-08-01
DK3272764T3 (da) 2024-05-06
EP2513134B1 (en) 2017-09-06
JP2013514073A (ja) 2013-04-25
EP2513134A1 (en) 2012-10-24
ES2651065T3 (es) 2018-01-24
WO2011073389A1 (en) 2011-06-23
SG10201408384PA (en) 2015-01-29
BR112012014937B1 (pt) 2021-01-19

Similar Documents

Publication Publication Date Title
CN102725304B (zh) 用于亲和色谱法的冲洗溶液和方法
CN103596968B (zh) 用于亲和层析的洗涤溶液和方法
US20120149878A1 (en) Protein purification
WO2023012828A1 (en) Method to purify an antibody composition using cation exchange chromatography
CN114901671B (zh) 用于亲和层析的新的清洗缓冲溶液
CN118725088A (zh) 一种疏水相互作用层析纯化IgM的方法及IgM纯化方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant